drugset / Trial / NCT06265077
Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
No randomized controlled trial evaluated the safety and efficacy of double blockade on G-CSF induced bone pain. Therefore, this study aims to evaluate the efficacy and safety of double blockade on the incidence and severity of G-CSF induced bone pain.
Timeline
- Start
- 2024-02-01
- Primary completion
- 2024-10-17
- Completion
- 2024-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Famotidine | Other / unclassified | 20 mg | — |
| Comparator | Loratadine | Small molecule | 10 mg | — |